Eyenovia Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Eyenovia's Strategic Collaborations and Innovative Optejet System Underpin Buy Rating
H.C. Wainwright Maintains Eyenovia(EYEN.US) With Buy Rating, Maintains Target Price $12
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Eyenovia Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)
HC Wainwright & Co. : The Eynovia (EYEN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $12.00.
Eyenovia Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Eyenovia Analyst Ratings
Eyenovia's Strategic Commercial Synergy and Growth Potential Reinforce Buy Rating
Eyenovia Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Kinnate Biopharma (KNTE), Relay Therapeutics (RLAY) and Eyenovia (EYEN)
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Eyenovia Analyst Ratings
Eyenovia Analyst Ratings
Brookline Capital Initiates Coverage On Eyenovia With Buy Rating, Announces Price Target of $8
Eyenovia Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target